Immune discovery should help develop improved vaccines for infants and newborns

July 10, 2018, Trinity College Dublin
Credit: CC0 Public Domain

Scientists have just identified a class of 'danger signals' that are highly efficient at triggering an immune response in infants and newborns. They believe their discovery may have the potential to reduce both the age of vaccine administration and the need for multiple booster injections in infants and newborns, whose immune systems operate differently to those of adults.

The scientists, from the School of Medicine, Trinity College Dublin, at the National Children's Research Centre (NCRC) in Ireland, have just published their findings in the prestigious Journal of Immunology.

Infection remains the most common cause of mortality in early life. Vaccination is by far the most effective intervention at preventing infectious disease, but newborn babies do not respond optimally to most vaccines due to their immature . For this reason immunisations are scheduled over the first 13 months of life to coincide with the maturation of the infant immune system. This leaves a window of time where and young infants are susceptible to -preventable infections, especially for vaccines such as the MMR that are only administered when a child is one year old.

Vaccines have two key components, one of which is an adjuvant. These adjuvants act as danger signals that instruct the immune system to mount a response to the infection, which in the case of a vaccine is usually an attenuated (reduced in virulence), inactive form, or a fragment of the bacteria or virus. The adjuvant is critical not only for triggering the immune system into action, but also for directing the type of response best suited to fight a particular infection.

Lead author of the study, Research Fellow in Trinity's School of Medicine, Dr. Kiva Brennan, said: "Many adjuvants used in vaccines today were developed in adults. However, babies and children are not simply little adults, and because of this, a child's immune system responds differently to that of an adult." As a result, key to improving vaccine efficacy is the design of adjuvants that specifically target and kick the newborn into action.

Scientists know that the formation of the microbiome is a critical step in a baby's development, where 'good bacteria' in the gut and on the skin establish and start functioning, and it is thought that newborns do not mount strong immune responses to allow for such colonisation by these commensal or 'good bacteria'. Viruses, however, have no beneficial function in newborns, which is why the scientists suspected that newborns may retain a more robust immune response to viruses. By exploring this theory, they found that a class of adjuvants that activate specialised sensors, which are critical in the response, drove a very strong immune response in newborns.

Commenting on the significance of the research, senior author, Assistant Professor in Immunology at Trinity, Dr. Sarah Doyle, said: "These sensors are normally activated in to viral and direct the immune system to clear viral infections. Harnessing these efficient anti-viral immune responses will help in the design of targeted adjuvants for paediatric vaccines by directly activating immune responses that are fully functional in infants and newborns."

"Improving paediatric vaccine efficacy has the potential to reduce both the age of administration and the need for multiple booster injections, likely increasing compliance and protecting more of the paediatric population with fewer doctors' visits."

Explore further: How live vaccines enhance the body's immune response

More information: Kiva Brennan et al, Type 1 IFN Induction by Cytosolic Nucleic Acid Is Intact in Neonatal Mononuclear Cells, Contrasting Starkly with Neonatal Hyporesponsiveness to TLR Ligation Due to Independence from Endosome-Mediated IRF3 Activation, The Journal of Immunology (2018). DOI: 10.4049/jimmunol.1700956

Related Stories

How live vaccines enhance the body's immune response

April 5, 2018
Universitätsmedizin Berlin, Berlin's university hospital, have discovered a new mechanism by which live vaccines induce immunity. Molecules produced exclusively by live microorganisms are recognized by specialized receptors ...

Trinity immunologists find new ways to beat the 'bad guys' (w/ Video)

March 2, 2016
From the current outbreak of the Zika virus to last year's Ebola, vaccines have a significant contribution to make in terms of public health. But why are they so important?

Boosting Newborns' Immune Responses

June 13, 2009
Newborn babies have immature immune systems, making them highly vulnerable to severe infections and unable to mount an effective immune response to most vaccines, thereby frustrating efforts to protect them. The World Health ...

Enhancing the immune response through next generation polymeric vaccine adjuvants

April 3, 2014
Adjuvants, such as aluminum salts, have been integrated into vaccines for more than 70 years to augment the body's immune response to pathogens. Adjuvants are especially necessary to boost the immune response for subunit ...

Two novel immune-response clusters identified to RSV

May 21, 2018
(HealthDay)—Two novel immune-response clusters have been identified to respiratory syncytial virus (RSV), and they are associated with first- and second-year recurrent wheeze, according to a study published online May 7 ...

What makes the newborn immune system in the lungs different and vulnerable?

February 13, 2014
Newborns are more susceptible to infections, presumably because of their immature and inexperienced immune systems. The most common dangerous condition in newborns and infants are lower respiratory tract infections caused ...

Recommended for you

Immunity connects gut bacteria and aging

November 13, 2018
Over the years, researchers have learned that the different populations of bacteria that inhabit the gut have significant effects on body functions, including the immune system. The populations of gut bacteria are sometimes ...

An enzyme in immune cells plays essential role in host defense against tuberculosis

November 13, 2018
Using freshly resected lung tissue from 21 patients and two distinct mouse models, tuberculosis researchers at the University of Alabama at Birmingham and the Africa Health Research Institute, or AHRI, have identified a protein ...

Probiotics increase bone volume in healthy mice

November 13, 2018
A widely-used probiotic stimulates bone formation in young female mice, according to a study published November 13th in the journal Immunity. In response to treatment with Lactobacillus rhamnosus GG (LGG), other intestinal ...

Study shows changes in histone methylation patterns in nutritionally stunted children

November 13, 2018
An international team of researchers has found changes in histone methylation patterns in nutritionally stunted children. In their paper published in Proceedings of the National Academy of Sciences, the group describes their ...

New clues to the origin and progression of multiple sclerosis

November 13, 2018
Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The ...

Cognitive decline—radiation—brain tumor prevented by temporarily shutting down immune response

November 13, 2018
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.